Johnson & Johnson’s standout trial results for its Tecvayli and Darzalex Faspro pairing in previously treated relapsed or ...
Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...
For patients facing a multiple myeloma diagnosis, the journey is often defined by a search for the next line of defense. For survivor Julie Cohen, that search led her to the front lines of medical ...
The management of smoldering multiple myeloma (MM) is undergoing a significant transformation, driven by growing evidence that early intervention can meaningfully delay progression to active disease.
MedPage Today on MSN
Myeloma combo with 'unprecedented' effect wins FDA approval
In second- or later-line setting, combination cut risk of disease progression or death by ...
On Thursday, the U.S. Food and Drug Administration approved Johnson & Johnson‘s JNJ Tecvayli in combination with Darzalex ...
Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...
Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced that the U.S. Food and Drug ...
Natco Pharma launched a cheaper generic version of the cancer drug ‘Pomalyst’ in the U.S. to treat multiple myeloma, making ...
Anemia often goes hand-in-hand with multiple myeloma. Sometimes, the cancer causes the anemia. And sometimes, the cancer treatment does. But it's possible to resolve it and feel better. (Photo Credit: ...
Tibetan tingsha bells are used as a brief pre-event grounding intervention, leveraging sustained high-frequency resonance to ...
How Does Multiple Myeloma Impact the Kidneys? Multiple myeloma is a cancer of plasma cells, a type of immune cell found in bone marrow. Healthy plasma cells make proteins called antibodies to fight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results